about
Bisphosphonate therapy in pediatric patientsDecreasing the duration of untreated illness for individuals with anorexia nervosa: study protocol of the evaluation of a systemic public health intervention at community levelResting Energy Expenditure in Anorexia Nervosa: Measured versus EstimatedEmerging drugs for eating disorder treatment.Gut microbiota composition in male rat models under different nutritional status and physical activity and its association with serum leptin and ghrelin levelsOrlistat for the management of overweight individuals and obesity: a review of potential for the 60-mg, over-the-counter dosage.Coercion is coercion? Reflections on trends in the use of compulsion in treating anorexia nervosa.Sex-dependent metabolic, neuroendocrine, and cognitive responses to dietary energy restriction and excessCurrent concepts in bone and reproductive health in adolescents with anorexia nervosa.Unique challenges for appropriate management of a 16-year-old girl with superior mesenteric artery syndrome as a result of anorexia nervosa: a case report.Genetic Deletion of Prostacyclin IP Receptor Exacerbates Transient Global Cerebral Ischemia in Aging Mice.Features and management of compulsive exercising in eating disorders.Reflections on involuntary treatment in the prevention of fatal anorexia nervosa: a review of five cases.Psychological change mechanisms in anorexia nervosa treatments: how much do we know?Benefits of caloric restriction for cardiometabolic health, including type 2 diabetes mellitus risk.Depression and cardiac dysautonomia in eating disorders.Circulating interleukin 6 and soluble forms of its receptors in relation to resting energy expenditure in women with anorexia nervosa.Predictors of late menarche and adult height in children with anorexia nervosa.Failure to feed patients with anorexia nervosa and other perils and perplexities in the medical care of eating disorder patients.The impact of weight normalization on quality of recovery in anorexia nervosa.Raynaud's phenomenon and nailfold capillaroscopic findings in anorexia nervosa.Hyperinsulinemia acutely increases serum macrophage inhibitory cytokine-1 concentration in anorexia nervosa and obesity.
P2860
Q26830702-3C55C151-A9B4-4F54-B87B-9FFCAC5EB526Q34551132-8DAD8228-DFA1-4656-800B-8054776C243DQ35220238-85950FAE-3CEF-495D-BFA1-F7C66CF50B86Q36458423-B583221E-3CAC-47E6-AE66-E0C6F5C9C53AQ36881567-3772BAD1-2982-4FE0-A5E8-7C048F3AF910Q36904913-52348F30-3EB0-489F-8EDE-2E1300FC6255Q36935418-1C164E5A-1688-4994-956B-3C2558E2ABFFQ37054514-279A337F-2E44-4FD2-8DAD-32CC71C832A6Q37055230-1E9F6EA6-3F9D-410B-9810-EAC08670837BQ37437447-D6D848AF-6533-4100-9335-D24B1C88236BQ37630989-CD1F4805-5250-4DC8-A7C3-B79A940789EDQ37667580-BF634B41-0D92-4E5B-B248-7CDEB0BB042CQ37846188-2C1C77F3-D7C5-4D74-9F32-23336861C6ABQ38076674-98B6F0ED-A66C-4AA4-9E94-179A90873D40Q38188495-AB3EDE46-AC50-4B22-9641-A4342BBE6AD2Q38937971-6C176335-115D-4F73-9C7D-82EE5DDD46C6Q42517198-D42A1C23-AA38-4B67-B964-00977EC9DD49Q43807379-52D07B11-EFC8-4125-A40B-1A7A0D92DE13Q44191591-4E2EA3C4-A85A-4F3B-8D9A-5DA9DADE4ED1Q47437526-E6A67E9C-D3CF-4690-A653-A322ED6840C2Q48324745-2EC83712-D736-49E4-AF15-D2105A72BA23Q51372416-40B21FDD-DFE9-4256-A239-165321315375
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Clinical practice. Anorexia nervosa.
@ast
Clinical practice. Anorexia nervosa.
@en
type
label
Clinical practice. Anorexia nervosa.
@ast
Clinical practice. Anorexia nervosa.
@en
prefLabel
Clinical practice. Anorexia nervosa.
@ast
Clinical practice. Anorexia nervosa.
@en
P356
P1476
Clinical practice. Anorexia nervosa.
@en
P2093
Arnold E Andersen
Joel Yager
P304
P356
10.1056/NEJMCP050187
P407
P577
2005-10-01T00:00:00Z